Intangible Assets and In-Process R&D - Narrative (Details) - USD ($) |
3 Months Ended | 9 Months Ended | ||||
|---|---|---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
Dec. 31, 2022 |
Sep. 30, 2018 |
|
| Finite-Lived Intangible Assets [Line Items] | ||||||
| In-Process R&D Impairment | $ 1,904,314 | $ 0 | $ 1,904,314 | $ 0 | ||
| Trade Secrets | ||||||
| Finite-Lived Intangible Assets [Line Items] | ||||||
| Trade Secrets | $ 250,000 | $ 250,000 | $ 250,000 | $ 300,000 | ||
| X | ||||||||||
- Definition Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|